Browse studies

Find your next paid study

4 recruiting studies matching your filters

A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

The purpose of this study is to determine the safety and tolerability of monotherapy CR-002 and to identify the MTD and/or optimal biologic dose and RP2D(s) in…

Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Gastric/GEJBiliary Tract Cancer (BTC)+5 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Crescent Biopharma, Inc.NCT07909031

Phase 2

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

This is a prospective study to evaluate the sensitivity and specificity of Cu-64 DOTA-ECL1i PET/CT imaging to serve as a novel precision imaging tool for patie…

Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Head and Neck Squamous Cell Carcinoma HNSCC

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Washington University School of MedicineNCT07659678

Phase 2

A Phase II Window of Opportunity in Preserving Laryngeal Function (WOLF) Trial

This trial will study the safety and tolerability and disease survival rates in adult patients with recurrent/metastatic (R/M) HNSCC when treated with carbopla…

Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Locally Advanced Laryngeal Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Matthew SpectorNCT07423078

Phase 2

Aspirin and PAClitaxel in Recurrent/Metastatic PI3K Altered Head & Neck Squamous Cell Carcinoma (HNSCC): APAC

This is a phase II trial of aspirin and paclitaxel in patients with recurrent/metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) who have received …

Head and Neck (HNSCC)Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Head and Neck Squamous Cell Carcinoma+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Washington University School of MedicineNCT07901803